EU Launches Research Effort into Common Links in Neurodegenerative Diseases

The European Union’s Joint Programme — Neurodegenerative Disease Research (JPND) invites researchers in 20 countries to work together in conducting and analyzing projects into various neurodegenerative diseases, so that they might identify common links and underlying mechanisms. Such “pathway ” analyses, the JPND said in a release, “could lead…

NFL star Steve Gleason will go down in history in New Orleans for his antics on the football field but his name will also be remembered off the field, for everything he did to raise awareness of amyotrophic lateral sclerosis (ALS). Discover seven interesting facts about ALS. Steve was diagnosed with…

Amyotrophic lateral sclerosis (ALS) is sometimes known as Lou Gehrig disease after the baseball player who famously suffered from it. Although ALS is a more common disease than we would like it to be, there is still little known about it and many are unaware of the details of the condition. That lack of…

High levels of 25-hydroxycholesterol, a cholesterol-related molecule, may trigger neuronal death and accelerate amyotrophic lateral sclerosis (ALS) progression, according to a new study. The finding could lead to new ALS therapies that target the molecule. The study, “25-Hydroxycholesterol Is Involved In The Pathogenesis Of Amyotrophic Lateral Sclerosis,” was published in the…

Low levels of vitamin D, found in the majority of patients with amyotrophic lateral sclerosis (ALS), are linked to more extensive loss of movement, but do not predict the course of disease over a year. Instead, researchers found that taking vitamin D supplements was associated with a faster decline. The study’s…

This video from ALSA Oregon is all about Pam Kofstad and her family. Pam’s health was on the decline for more than a year, starting with the inability to turn her left foot out and often tripping, which led to her being confined to a wheelchair. In April 2015, Pam was diagnosed with amyotrophic…

The Duke University ALS Clinic and the Freelon Foundation have announced a partnership to expand the school’s research on amyotrophic lateral sclerosis (ALS). The partnership will involve establishing an endowed professorship, providing funding for clinical trials, and increasing the number of patients the clinic can treat. Phil Freelon, who founded the Freelon Foundation…

Genervon Biopharmaceuticals has published a list of 89 genes associated with amyotrophic lateral sclerosis (ALS) that are modulated by its drug candidate GM6. The identification of the genes regulated by GM6 helps to explain the mechanism of action of this treatment, which aims to improve neuronal repair and survival, and…

Amyotrophic lateral sclerosis (ALS) is sometimes known as Lou Gehrig disease after the baseball player who famously suffered from the disease. We’ve listed seven facts about ALS you should know about with help from prevention.com and the ALS Therapy Development Institute.   The first symptoms of ALS usually appear…

A new program at the University of Pennsylvania will pursue ways to use gene therapy and genome editing to treat amyotrophic lateral sclerosis (ALS). The Program of Excellence for Motor Neuron Disease, launched by researchers at the Orphan Disease Center (ODC) in the university’s Perelman School of Medicine, will receive…